Financial Evaluation of Kidney Transplant With Hepatitis C Viremic Donors to Uninfected Recipients

Kidney transplantation with hepatitis C viremic (dHCV+) donors appears safe for recipients without HCV when accompanied by direct acting antiviral (DAA) treatment. However, US programs have been reluctant to embrace this approach due to concern about insurance coverage. While the cost of DAA treatme...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Transplant Direct
Hauptverfasser: Axelrod, David A., Lentine, Krista L., Balakrishnan, Ramji, Chang, Su-Hsin, Alhamad, Terek, Xiao, Huiling, Kasiske, Bertran L., Bloom, Roy D., Schnitzler, Mark A.
Format: Artigo
Sprache:Inglês
Veröffentlicht: Lippincott Williams & Wilkins 2020
Schlagworte:
Kidney Transplantation
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7665247/
https://ncbi.nlm.nih.gov/pubmed/33204825
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/TXD.0000000000001056
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge